The following statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased VBI Vaccines Inc.
(NASDAQ:VBIV) stock prior to October 26, 2015.
You are hereby notified that Levi & Korsinsky, LLP has commenced
an investigation into the fairness of the sale of VBI Vaccines
Inc. to SciVac Therapeutics Inc. for 20.808356 common shares of
SciVac per share. VBI shareholders will own approximately 42% of the
outstanding shares of the post-merger entity; VBI will survive as a
subsidiary of SciVac and SciVac will change its name to VBI Vaccines
Inc. To learn more about the investigation and your rights, go to:
http://zlk.9nl.com/vbi-vaccines-vbiv
or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There
is no cost or obligation to you.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut and Washington D.C. The firm’s attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities lawsuits and have recovered hundreds of millions of
dollars for aggrieved shareholders. For more information, please
feel free to contact any of the attorneys listed below. Attorney
advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky,
Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel:
(212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20151030005617/en/
Copyright Business Wire 2015